相关实验视频
Updated: May 12, 2026
07:01
Pre-clinical Orthotopic Murine Model of Human Prostate Cancer
Published on: August 29, 2016
14.1K
前列腺癌基金会关于转移性激素敏感前列腺癌组合疗法的白皮书
Sigrid V Carlsson1,2,3,4, Pedro C Barata5, Alan H Bryce6
1Department of Surgery (Urology Service), Memorial Sloan Kettering Cancer Center, New York, NY.
JCO oncology practice
|May 2, 2025
概括
尽管对于转移性激素敏感前列腺癌 (mHSPC) 的组合疗法的已被证明是有益的,但由于进入障碍,许多患者仍然未得到充分治疗. 这个前列腺癌基金会 (PCF) 的倡议旨在改善护理服务,并确保公平获得基于证据的治疗方法.
科学领域:
- 在瘤学瘤学.
- 医疗信息学 医疗信息学
- 医疗保健服务研究 医疗服务研究
背景情况:
- 随机对照试验证实,组合疗法可以改善转移性激素敏感前列腺癌 (mHSPC) 的生存率和生活质量.
- 仍然存在很大的治疗差距,20%-60%的符合条件的mHSPC患者未得到治疗.
- 治疗机会的差异受地理,金融和系统因素以及患者人口统计学的影响.
研究的目的:
- 解决mHSPC护理的关键挑战,并确定弥合治疗差距的策略.
- 分析现实世界的证据和元分析,以了解治疗利用模式和差异.
- 促进所有mHSPC患者平等获得基于证据的组合疗法.
主要方法:
- 召集多方利益相关者倡议 (学术界,社区实践,行业,患者倡导).
- 从全球注册表 (例如,IRONMAN) 和社区数据库中审查了现实世界的证据.
- 进行了专家讨论,并分析了mHSPC治疗的元分析.
主要成果:
- 组合疗法 (ADT + ARPI或ADT + ARPI + docetaxel) 显著改善了治疗结果.
- 观察到不一致的组合疗法的采用,治疗不足率为20%-60%.
- 在地理位置,实践类型和患者人口统计学 (例如种族,城市与农村) 中发现了治疗差异.
结论:
- 改善mHSPC护理需要解决意识,标准化和公平获得符合指导方针的治疗方法.
- 有针对性的知识传播,教育资源和政策宣传至关重要.
- 合作努力对于提高所有mHSPC患者的生存率和生活质量至关重要.
更多相关视频
07:25A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
12.9K
06:32Intra-Cardiac Injection of Human Prostate Cancer Cells to Create a Bone Metastasis Xenograft Mouse Model
Published on: November 4, 2022
4.3K
相关概念视频
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
01:30Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...